Document Detail

Time savings associated with C.E.R.A. once monthly: a time-and-motion study in haemodialysis centres in five European countries.
MedLine Citation:
PMID:  23402559     Owner:  NLM     Status:  Publisher    
Abstract Objective: This time-and-motion study aimed to quantify health-care personnel time associated with routine anaemia-management tasks for maintenance therapy with C.E.R.A. (continuous erythropoietin receptor activator) that treats anaemia with once-monthly injections versus other erythropoiesis -stimulating agents ("Other ESAs"), including shorter-acting ESAs (epoetin alfa, epeotin beta) and darbepoetin alfa. Methods and design: This was a non-interventional, observational study where patients were treated for anaemia according to individual centre practices. Time taken to complete frequent anaemia-management tasks for both groups (C.E.R.A. vs "Other ESAs") was recorded and potential annual time savings per patient and per centre following assumed 100% uptake of C.E.R.A. once monthly were estimated. Results: For "Other ESAs", the average total time spent per patient per year on frequent anaemia management-related tasks ranged from 48 minutes in Spain to 265 in Poland. For C.E.R.A. once monthly, the average total time spent per patient per year ranged from 12 minutes in Spain to 39 in Poland, a reduction in actual time spent of 76-89% versus "Other ESAs". 100% adoption of C.E.R.A. once monthly may result in average annual time savings of 26-553 hours, a reduction of 67-95% depending on centre size and frequency distribution of "Other ESAs". Limitations: Due to variability in treatment practices between centres (differences in task, description and frequency distribution of "Other ESAs") and the small numbers of centres participating in each country, it is difficult to generalise annual per patient time results to reflect each country. Per centre results should be interpreted with caution as they were derived based on specific centre sizes that may not reflect typical centre sizes in the country. Conclusions: Adoption of C.E.R.A. once monthly could offer substantial time savings on frequent anaemia management-related tasks versus "Other ESAs"; allowing re-allocation of scarce resources to other aspects of patient care.
Erwin De Cock; Frank Dellanna; Karim Khellaf; Wieslaw Klatko; Francisco Maduell; Mireia Raluy-Callado; Giuseppe Villa
Related Documents :
18525229 - Peripheral arteriovenous malformations with a dominant outflow vein: results of ethanol...
20584469 - Endovascular treatment of cerebral avm: our experience with onyx.
10094359 - Radiation dose to patients and personnel during intraoperative digital subtraction angi...
25127679 - Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer...
908489 - Effects of abdominal surgery on the development of radiation enteropathy.
16195839 - Clinical and radiological long-term follow-up after embolization of pulmonary arteriove...
3654709 - Synovectomy of the rheumatoid knee using intra-articular injection of dysprosium-165-fe...
16807979 - Effects of metoclopramide and ranitidine on preoperative gastric contents in day-case s...
8765459 - Management of psoriasis with aloe vera extract in a hydrophilic cream: a placebo-contro...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-12
Journal Detail:
Title:  Journal of medical economics     Volume:  -     ISSN:  1941-837X     ISO Abbreviation:  J Med Econ     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9892255     Medline TA:  J Med Econ     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
United BioSource Corporation, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  How hard can it be to include research evidence and evaluation in local health policy implementation...
Next Document:  Outcomes Associated with Concordance of Oral Antidiabetic Drug Treatments to Prescribing Information...